Your browser doesn't support javascript.
loading
A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis.
Trojano, Maria; Ramió-Torrentà, Lluís; Grimaldi, Luigi Me; Lubetzki, Catherine; Schippling, Sven; Evans, Karleyton C; Ren, Zheng; Muralidharan, Kumar Kandadi; Licata, Stephanie; Gafson, Arie R.
Affiliation
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.
  • Ramió-Torrentà L; Neurology Department, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Medical Sciences Department, University of Girona, Girona, Spain.
  • Grimaldi LM; Unità Operativa Neurologia, Fondazione Istituto San Raffaele G. Giglio di Cefalù, Cefalù, Italy.
  • Lubetzki C; Sorbonne University and Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Department of Neurology, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Schippling S; Neuroimmunology and Multiple Sclerosis Research Section, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Evans KC; Biogen, Cambridge, MA, USA.
  • Ren Z; Biogen, Cambridge, MA, USA.
  • Muralidharan KK; Biogen, Cambridge, MA, USA.
  • Licata S; Biogen, Cambridge, MA, USA.
  • Gafson AR; Biogen, Cambridge, MA, USA.
Mult Scler ; 27(14): 2240-2253, 2021 12.
Article in En | MEDLINE | ID: mdl-33821693

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Year: 2021 Document type: Article